Endocrine disrupting chemicals affect the Gonadotropin releasing hormone neuronal network

Reproductive Toxicology

Volumn 44, Issue , 2014, Pages 73-84

  Mueller, Johanna K ^a   Heger, Sabine ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Children's Hospital Auf der Bult   (Germany)

Author keywords

EAP1; Endocrine disrupting chemicals; KiSS1; Puberty; Transcription

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4,4' ISOPROPYLIDENEDIPHENOL; BENZHYDRYL DERIVATIVE; ENDOCRINE DISRUPTOR; GENISTEIN; GONADORELIN; KISS1 PROTEIN, HUMAN; KISSPEPTIN; PHENOL DERIVATIVE; PHYTOESTROGEN; PITUITARY TUMOR-TRANSFORMING PROTEIN 1, HUMAN; SECURIN; TRANSCRIPTION FACTOR YY1; YY1 PROTEIN, RAT;

ANIMAL; CELL CULTURE; CELL LINE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYPOTHALAMUS; METABOLISM; MOUSE; NERVE CELL; PROMOTER REGION; REPORTER GENE; SPRAGUE DAWLEY RAT; TOXICITY;

ANIMALS; BENZHYDRYL COMPOUNDS; CELL LINE; CELLS, CULTURED; ENDOCRINE DISRUPTORS; GENE EXPRESSION REGULATION; GENES, REPORTER; GENISTEIN; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYPOTHALAMUS; KISSPEPTINS; MICE; NEURONS; PHENOLS; PHYTOESTROGENS; PROMOTER REGIONS, GENETIC; RATS, SPRAGUE-DAWLEY; SECURIN; TETRACHLORODIBENZODIOXIN; YY1 TRANSCRIPTION FACTOR;

EID: 84899412558     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2013.10.011     Document Type: Article

References (67)

1. Diamanti-Kandarakis E., Bourguignon J.P., Giudice L.C., Hauser R., Prins G.S., Soto A.M., et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 2009, 30(4):293-342.
2. Thundiyil J.G., Solomon G.M., Miller M.D. Transgenerational exposures: persistent chemical pollutants in the environment and breast milk. Pediatr Clin North Am 2011, 54(1):81-101.
3. Vehlow J., Bergfeldt B., Hunsinger H. PCDD/F and related compounds in solid residues from municipal solid waste incineration - a literature review. Waste Manage Res 2006, 24(5):404-420.
4. Frye C., Bo E., Calamandrei G., Calzà L., Dessi-Fulgheri F., Fernández M., et al. Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behavior and neuroendocrine systems. J Neuroendocrinol 2012, 24(1):144-159.
5. Parent A.S., Rasier G., Gerard A., Heger S., Roth C., Mastronardi C. Early onset of puberty: tracking genetic and environmental factors. Horm Res 2005, 64(Suppl. 2):41-47.
6. Krstevska-Konstantinova M., Charlier C., Craen M., Du C.M., Heinrichs C., de Beaufort C., et al. Sexual precocity after immigration from developing countries to Belgium: evidence of previous exposure to organochlorine pesticides. Hum Reprod 2001, 16(5):1020-1026.
7. Manach C., Scalbert A., Morand C., Rémésy C., Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004, 79(5):727-747.
8. Bateman H.L., Patisaul H.B. Disrupted female reproductive physiology following neonatal exposure to phytoestrogens or estrogen specific ligands is associated with decreased GnRH activation and kisspeptin fiber density in the hypothalamus. Neurotoxicology 2008, 29(6):988-997.
9. Kim J., Kim S., Huh K., Kim Y., Joung H., Park M. High serum isoflavone concentrations are associated with the risk of precocious puberty in Korean girls. Clin Endocrinol (Oxf) 2011, 75(6):831-835.
10. Adewale H.B., Jefferson W.N., Newbold R.R., Patisaul H.B. Neonatal bisphenol-a exposure alters rat reproductive development and ovarian morphology without impairing activation of gonadotropin-releasing hormone neurons. Biol Reprod 2009, 81(4):690-699.
11. Adewale H.B., Todd K.L., Mickens J.A., Patisaul H.B. The impact of neonatal bisphenol-a exposure on sexually dimorphic hypothalamic nuclei in the female rat. Neurotoxicology 2011, 32(1):38-49.
12. Durando M., Kass L., Piva J., Sonnenschein C., Soto A.M., Luque E.H., et al. Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect 2007, 115(1):80-86.
13. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., et al. Mechanisms of estrogen action. Physiol Rev 2001, 81(4):1535-1565.
14. Klinge C.M. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 2001, 29(14):2905-2919.
15. Hayashi S., Yamaguchi Y. Estrogen signaling pathway and hormonal therapy. Breast Cancer 2008, 15(4):256-261.
16. Filardo E.J., Quinn J.A., Frackelton A.R., Bland K.I. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 2002, 16(1):70-84.
17. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307(5715):1625-1630.
18. Safe S., Pallaroni L., Yoon K., Gaido K., Ross S., McDonnell D. Problems for risk assessment of endocrine-active estrogenic compounds. Environ Health Perspect 2002, 110(Suppl. 6):925-929.
19. Seo B.W., Li M.H., Hansen L.G., Moore R.W., Peterson R.E., Schantz S.L. Effects of gestational and lactational exposure to coplanar polychlorinated biphenyl (PCB) congeners or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thyroid hormone concentrations in weanling rats. Toxicol Lett 1995, 78(3):253-262.
20. Grassman J.A., Masten S.A., Walker N.J., Lucier G.W. Animal models of human response to dioxins. Environ Health Perspect 1998, 106(Suppl. 2):761-775.
21. Safe S., Krishnan V. Chlorinated hydrocarbons: estrogens and antiestrogens?. Toxicol Lett 1995, 1995(82-83):731-736.
22. Safe S., Krishnan V. Cellular and molecular biology of aryl hydrocarbon (Ah) receptor-mediated gene expression. Arch Toxicol Suppl 2011, 1995(17):99-115.
23. Ohtake F., Takeyama K., Matsumoto T., Kitagawa H., Yamamoto Y., Nohara K., et al. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 2003, 423(6939):545-550.
24. Matthews J., Wihlen B., Thomsen J., Gustafsson J.A. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor {alpha} to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters. Mol Cell Biol 2005, 25(13):5317-5328.
25. Mimura J., Fujii-Kuriyama Y. Functional role of AhR in the expression of toxic effects by TCDD. Biochim Biophys Acta 2003, 1619(3):263-268.
26. Denison M.S., Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 2003, 43:309-334.
27. Lomniczi A., Loche A., Castellano J.M., Ronnekleiv O.K., Bosch M., Kaidar G., et al. Epigenetic control of female puberty. Nat Neurosci 2013, 16(3):281-289.
28. Wilkinson F.H., Park K., Atchison M.L. Polycomb recruitment to DNA in vivo by the YY1 REPO domain. Proc Natl Acad Sci U S A 2006, 103(51):19296-19301.
29. Roth C.L., Mastronardi C., Lomniczi A., Wright H., Cabrera R., Mungenast A.E., et al. Expression of a tumor related gene network increases in the mammalian hypothalamus at the time of female puberty. Endocrinology 2007, 11:5147-5161.
30. Mueller J.K., Koch I., Lomniczi A., Loche A., Rulfs T., Castellano J.M., et al. Transcription of the human EAP1 gene is regulated by upstream components of a puberty-controlling Tumor Suppressor Gene network. Mol Cell Endocrinol 2012, 351(2):184-198.
31. Mueller J.K., Dietzel A., Lomniczi A., Loche A., Tefs K., Kiess W., et al. Transcriptional regulation of the human KiSS1 gene. Mol Cell Endocrinol 2011, 342:8-19.
32. Heger S., Mastronardi C., Dissen G.A., Lomniczi A., Cabrera R., Roth C.L., et al. Enhanced at puberty 1 (EAP1) is a new transcriptional regulator of the female neuroendocrine reproductive axis. J Clin Invest 2007, 117:2145-2154.
33. Dissen G.A., Lomniczi A., Heger S., Neff T.L., Ojeda S.R. Hypothalamic EAP1 (enhanced at puberty 1) is required for menstrual cyclicity in nonhuman primates. Endocrinology 2012, 153(1):350-361.
34. Seminara S.B., Messager S., Chatzidaki E.E., Thresher R.R., Acierno J.S., Shagoury J.K., et al. The GPR54 gene as a regulator of puberty. N Engl J Med 2003, 349:1614-1627.
35. Heindel J.J., Levin E. Developmental origins and environmental influences - introduction. Birth Defects Res A Clin Mol Teratol 2005, 73(7):469.
36. Heindel J.J. The fetal basis of adult disease: role of environmental exposures - introduction. Birth Defects Res A Clin Mol Teratol 2005, 73(3):131-132.
37. Patisaul H.B., Adewale H.B. Long-term effects of environmental endocrine disruptors on reproductive physiology and behavior. Front Behav Neurosci 2009, 3:10.
38. Vandenberg L.N., Maffini M.V., Sonnenschein C., Rubin B.S., Soto A.M. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 2009, 30(1):75-95.
39. Gore A.C., Patisaul H.B. Neuroendocrine disruption: historical roots, current progress, questions for the future. Front Neuroendocrinol 2010, 31:395-399.
40. Adan R.A., Cox J.J., van Kats J.P., Burbach J.P. Thyroid hormone regulates the oxytocin gene. J Biol Chem 1992, 267(6):3771-3777.
41. Schug J. Using TESS to predict transcription factor binding sites in DNA sequence. Curr Protoc Bioinformatics 2008, Chapter 2:Unit.
42. Huijbregts L., de Roux N. KISS1 is down-regulated by 17beta-estradiol in MDA-MB-231 cells through a nonclassical mechanism and loss of ribonucleic acid polymerase II binding at the proximal promoter. Endocrinology 2010, 151(8):3764-3772.
43. D'Anglemont de Tassigny X., Campagne C., Steculorum S., Prevot V. Estradiol induces physical association of neuronal nitric oxide synthase with NMDA receptor and promotes nitric oxide formation via estrogen receptor activation in primary neuronal cultures. J Neurochem 2009, 109(1):214-224.
44. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25(4):402-408.
45. Simon P. Q-Gene: processing quantitative real-time RT-PCR data. Bioinformatics 2003, 19(11):1439-1440.
46. Eng L.F., Ghirnikar R.S., Lee Y.L. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000)?. Neurochem Res 2000, 25(9-10):1439-1451.
47. Di Stefano G., Casoli T., Fattoretti P., Gracciotti N., Solazzi M., Bertoni-Freddari C. Distribution of map2 in hippocampus and cerebellum of young and old rats by quantitative immunohistochemistry. J Histochem Cytochem 2001, 49(8):1065-1066.
48. Sharif A., Prevot V. Isolation and culture of human astrocytes. Methods in molecular biology 2012, Springer Science+Business Media, New York, Dordrecht, Heidelberg, London.
49. Safe S. Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm 2001, 62:231-252.
50. Safe S., Kim K. Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J Mol Endocrinol 2008, 41(5):263-275.
51. Minh S.D., Below S., Mueller C., Hildebrandt J.P. Novel mammalian cell lines expressing reporter genes for the detection of environmental chemicals activating endogenous aryl hydrocarbon receptors (ArhR) or estrogen receptors (ER). Toxicol In Vitro 2008, 22(8):1935-1947.
52. Oakley A.E., Clifton D.K., Steiner R.A. Kisspeptin signaling in the brain. Endocr Rev 2009, 30(6):713-743.
53. Parent A.S., Krstevska-Konstantinova M., Matagne V., Gerard A., Lebrethon M.C., Charlier C., et al. Endocrine disrupter contribution to sexual precocity: suggestive detection of pesticide derivatives in patients immigrant to Belgium and stimulation of GnRH pulsatility in rat hypothalamus. Pediatr Res 2001, 49:139A.
54. Jefferson W.N., Padilla-Banks E., Newbold R.R. Adverse effects on female development and reproduction in CD-1 mice following neonatal exposure to the phytoestrogen genistein at environmentally relevant doses. Biol Reprod 2005, 73(4):798-806.
55. Jefferson W., Newbold R., Padilla-Banks E., Pepling M. Neonatal genistein treatment alters ovarian differentiation in the mouse: inhibition of oocyte nest breakdown and increased oocyte survival. Biol Reprod 2006, 74(1):161-168.
56. Lewis R.W., Brooks N., Milburn G.M., Soames A., Stone S., Hall M., et al. The effects of the phytoestrogen genistein on the postnatal development of the rat. Toxicol Sci 2003, 71(1):74-83.
57. Patisaul H.B., Fortino A.E., Polston E.K. Differential disruption of nuclear volume and neuronal phenotype in the preoptic area by neonatal exposure to genistein and bisphenol-A. Neurotoxicology 2007, 28(1):1-12.
58. Patisaul H.B., Polston E.K. Influence of endocrine active compounds on the developing rodent brain. Brain Res Rev 2008, 57(2):352-362.
59. Howdeshell K.L., Hotchkiss A.K., Thayer K.A., Vandenbergh J.G., vom Saal F.S. Exposure to bisphenol A advances puberty. Nature 1999, 401(6755):763-764.
60. Woo C.J., Kharchenko P.V., Daheron L., Park P.J., Kingston R.E. A region of the human HOXD cluster that confers polycomb-group responsiveness. Cell 2010, 140(1):99-110.
61. Teng A.C., Kuraitis D., Deeke S.A., Ahmadi A., Dugan S.G., Cheng B.L., et al. IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression. FASEB J 2010, 24(12):4825-4834.
62. Vandegehuchte M.B., Janssen C.R. Epigenetics and its implications for ecotoxicology. Ecotoxicology 2011, 20(3):607-624.
63. Gowher H., Jeltsch A. Enzymatic properties of recombinant Dnmt3a DNA methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner and also methylates non-CpA sites. J Mol Biol 2001, 309(5):1201-1208.
64. Aoki A., Suetake I., Miyagawa J., Fujio T., Chijiwa T., Sasaki H., et al. Enzymatic properties of de novo-type mouse DNA (cytosine-5) methyltransferases. Nucleic Acids Res 2001, 29(17):3506-3512.
65. Feng J., Chang H., Li E., Fan G. Dynamic expression of de novo DNA methyltransferases Dnmt3a and Dnmt3b in the central nervous system. J Neurosci Res 2005, 79(6):734-746.
66. Gray L.E., Ostby J.S. In utero 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters reproductive morphology and function in female rat offspring. Toxicol Appl Pharmacol 1995, 133(2):285-294.
67. Waye A., Trudeau V.L. Neuroendocrine disruption: more than hormones are upset. J Toxicol Environ Health B Crit Rev 2011, 14:270-291.